Brief: Iol Chemicals And Pharmaceuticals Says European Directorate For Quality Of Medicines & Healthcare Grants Certificate For Fenofibrate–Process II
BRIEF-Iol Chemicals And Pharmaceuticals Says European Directorate For Quality Of Medicines & Healthcare Grants Certificate For Fenofibrate–Process II Sept 25 (Reuters) - IOL Chemicals and Pharmaceuticals Ltd IOLC.NS:
IOL CHEMICALS AND PHARMACEUTICALS LTD- EUROPEAN DIRECTORATE FOR QUALITY OF MEDICINES & HEALTHCARE GRANTS SUITABILITY CERTIFICATE FOR FENOFIBRATE– PROCESS II
Source text: [ID:]
Further company coverage: IOLC.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IOL Chemicals and Pharmaceuticals
See all newsBrief: Iol Chemicals And Pharmaceuticals Says European Directorate For Quality Of Medicines & Healthcare Grants Certificate For Fenofibrate–Process II
Brief: IOL Chemicals And Pharmaceuticals June-Quarter Consol Profit 644 Million Rupees
Brief: IOL Chemicals and Pharmaceuticals Gets Approval From NMPA, China For Clopidogrel Bisulfate API
Brief: IOL Chemicals And Pharmaceuticals Reports Minor Fire Incident In Unit-9B Minoxidil Manufacturing Unit On June 9
Brief: IOL Chemicals And Pharmaceuticals March-Quarter Consol Profit 531.6 Million Rupees